Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 8/20 | 0.53 |
| ▸ | FNTB | P49356 | 8/20 | 0.53 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3791908 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL17823046 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL30588905 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL1157690 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL2306808 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL2312650 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL1157691 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL17823048 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL2306806 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL2312960 | 1.00 | LMNA (0.57) | LMNAFNTAFNTBPGGT1BCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4271666-B1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-12-18 | — | — | EP | claimed |
| US-20240083858-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-03-14 | — | — | US | claimed |
| EP-4271666-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | Evonik Operations GmbH (DE) | 2023-11-08 | — | — | EP | claimed |
| CN-116802173-A | Process for the preparation of diastereomerically pure DL/LD-methionyl methionine | 赢创运营有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2022144292-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2022-07-07 | — | — | WO | claimed |
| WO-2022144293-A1 | PROCESS FOR PRODUCING PARTICULATE METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2022-07-07 | — | — | WO | claimed |
| EP-4023637-A1 | METHOD FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | claimed |
| EP-4023662-A1 | METHOD FOR PRODUCING PARTICULATE METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | claimed |
| EP-4271666-B1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-12-18 | — | — | EP | disclosed |
| EP-4271666-B1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-12-18 | — | — | EP | disclosed |
| US-20240083858-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-03-14 | — | — | US | disclosed |
| US-20240083858-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-03-14 | — | — | US | disclosed |
| US-20240083858-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2024-03-14 | — | — | US | disclosed |
| EP-4271666-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | Evonik Operations GmbH (DE) | 2023-11-08 | — | — | EP | disclosed |
| WO-2022144292-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022144292-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | EVONIK OPERATIONS GMBH (DE) | 2022-07-07 | — | — | WO | disclosed |
| EP-4023637-A1 | METHOD FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
| EP-4023662-A1 | METHOD FOR PRODUCING PARTICULATE METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
| EP-4023637-A1 | METHOD FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
| EP-4023662-A1 | METHOD FOR PRODUCING PARTICULATE METHIONYL-METHIONINE | Evonik Operations GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083858-A1 | PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE | DDT, DLD, DDC | LMNA 1499/4885FNTA 2911/4885FNTB 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.